Stable sugar-based protein formulations by supercritical fluid drying.
The aim of this work was to produce stable, sugar-containing protein formulations by supercritical fluid (SCF) drying. Lysozyme solutions with and without added sucrose or trehalose were dried by spraying them in an SCF composed of CO(2) and ethanol or CO(2) only. The protein-to-sugar ratio was varied between 1:0 and 1:10 (w/w). Dried formulations were stored at 4 degrees C for three months and analyzed by Karl Fischer titration, scanning electron microscopy, X-ray powder diffraction, differential scanning calorimetry and Fourier transform infrared spectroscopy. Lysozyme stability after reconstitution was determined by an enzymatic activity assay, UV/Vis spectroscopy, and SDS-PAGE. Smooth, spherical particles of 1-25 microm size were obtained. All formulations were initially amorphous. Crystallization during storage only occurred with a protein-to-sugar ratio of 1:10 and could be avoided by performing SCF drying without ethanol. Absence of residual ethanol in dried trehalose formulations increased the glass transition temperature up to 120 degrees C. Lysozyme in dried formulations was structurally stable, with exception of the 1:0 and 1:1 protein-to-sugar ratios, where reversible protein aggregation occurred. The results show that by avoiding ethanol, which up to now has been considered mandatory for efficient drying of aqueous solutions, and by choosing the proper protein-to-sugar ratio, it is possible to obtain stable, sugar-based protein formulations through SCF drying.
Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences (UIPS), 3508 TB Utrecht, The Netherlands.
Natasa
N
Jovanović
Andréanne
A
Bouchard
Marc
M
Sutter
Michiel
M
Van Speybroeck
Gerard W
GW
Hofland
Geert-Jan
GJ
Witkamp
Daan J A
DJ
Crommelin
Wim
W
Jiskoot
D002152:Calorimetry, Differential Scanning; D002245:Carbon Dioxide / Q000737:chemistry; D003460:Crystallization; D003890:Desiccation / Q000379:methods; D004339:Drug Compounding / Q000379:methods; D004355:Drug Stability; D004356:Drug Storage; D000431:Ethanol / Q000032:analysis / Q000737:chemistry; D008855:Microscopy, Electron, Scanning; D009113:Muramidase / Q000737:chemistry* / Q000378:metabolism; D010316:Particle Size; D011208:Powders; D017550:Spectroscopy, Fourier Transform Infrared; D013395:Sucrose / Q000737:chemistry*; D014199:Trehalose / Q000737:chemistry*; D014867:Water / Q000032:analysis; D014961:X-Ray Diffraction
D011208:Powders; D014867:Water; D002245:Carbon Dioxide; D000431:Ethanol; D013395:Sucrose; D014199:Trehalose; D009113:Muramidase